Insulin Glargine Recall; Obesity & Endometrial Cancer; Red Light for Testosterone?
(MedPage Today) -- Mylan Pharmaceuticals voluntarily recalled one batch of unbranded insulin glargine injection 100 units/mL (insulin glargine-yfgn) due to a possible missing label, the FDA announced.
Infertility was tied to a 16% higher risk...
Source: MedPage Today Endocrinology - Category: Endocrinology Source Type: news
More News: Cancer | Cancer & Oncology | Eating Disorders & Weight Management | Endocrinology | Endometrial Cancer | Infertility | Insulin | Lantus | Obesity | Reproduction Medicine